Sanders Morris Harris’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | – | Sell |
-1,900
| Closed | -$556K | – | 133 |
|
|
2026
Q1 | $556K | Buy |
+1,900
| New | +$624K | 0.09% | 172 |
|
|
2025
Q4 | – | Sell |
-1,900
| Closed | -$614K | – | 115 |
|
|
2025
Q3 | $614K | Buy |
+1,900
| New | +$591K | 0.08% | 155 |
|
|
2025
Q2 | – | Sell |
-1,900
| Closed | -$822K | – | 208 |
|
|
2025
Q1 | $822K | Hold |
1,900
| – | – | 0.13% | 108 |
|
|
2024
Q4 | $701K | Hold |
1,900
| – | – | 0.1% | 137 |
|
|
2024
Q3 | $988K | Hold |
1,900
| – | – | 0.16% | 92 |
|
|
2024
Q2 | $1.03M | Hold |
1,900
| – | – | 0.17% | 82 |
|
|
2024
Q1 | $985K | Hold |
1,900
| – | – | 0.18% | 91 |
|
|
2023
Q4 | $909K | Hold |
1,900
| – | – | 0.45% | 58 |
|
|
2023
Q3 | $831K | Hold |
1,900
| – | – | 0.17% | 86 |
|
|
2023
Q2 | $845K | Buy |
+1,900
| New | +$877K | 0.19% | 78 |
|
|
2023
Q1 | – | Sell |
-1,900
| Closed | -$975K | – | 182 |
|
|
2022
Q4 | $975K | Hold |
1,900
| – | – | 0.37% | 51 |
|
|
2022
Q3 | $893K | Hold |
1,900
| – | – | 0.22% | 71 |
|
|
2022
Q2 | $923K | Hold |
1,900
| – | – | 0.2% | 78 |
|
|
2022
Q1 | $933K | Hold |
1,900
| – | – | 0.18% | 91 |
|
|
2021
Q4 | $878K | Hold |
1,900
| – | – | 0.15% | 98 |
|
|
2021
Q3 | $723K | Hold |
1,900
| – | – | 0.13% | 120 |
|
|
2021
Q2 | $732K | Hold |
1,900
| – | – | 0.14% | 125 |
|
|
2021
Q1 | $669K | Hold |
1,900
| – | – | 0.14% | 118 |
|
|
2020
Q4 | $628K | Hold |
1,900
| – | – | 0.14% | 126 |
|
|
2020
Q3 | $563K | Buy |
1,900
+1,119
| +143% | +$301K | 0.15% | 123 |
|
|
2020
Q2 | $210K | Buy |
+781
| New | +$208K | 0.1% | 107 |
|
|
2020
Q1 | – | Sell |
-2,000
| Closed | -$602K | – | 198 |
|
|
2019
Q4 | $602K | Hold |
2,000
| – | – | 0.14% | 150 |
|
|
2019
Q3 | $481K | Hold |
2,000
| – | – | 0.12% | 147 |
|
|
2019
Q2 | $563K | Buy |
+2,000
| New | +$546K | 0.15% | 134 |
|
|
2018
Q3 | – | Sell |
-2,760
| Closed | -$657K | – | 137 |
|
|
2018
Q2 | $657K | Sell |
2,760
-240
| -8% | -$55.6K | 0.3% | 51 |
|
|
2018
Q1 | $658K | Buy |
+3,000
| New | +$705K | 0.28% | 63 |
|
Other funds holding ELV
Sanders Morris Harris's ELV Position: Q2 2026 in Review
Sanders Morris Harris sold out of Elevance Health (ELV) in Q2 2026, closing a stake of 1,900 shares — an estimated $556K sold.
Sanders Morris Harris first reported a position in ELV in Q1 2018 and held it in 26 quarters. The position peaked at $1.03M in Q2 2024. 1,600 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- Sanders Morris Harris reported no remaining Elevance Health position as of Q2 2026 after selling out during the quarter.
- Sanders Morris Harris sold 1,900 Elevance Health shares in Q2 2026, an estimated $556K.
- Sanders Morris Harris first reported a position in Elevance Health in Q1 2018 and held it in 26 quarters.
- Sanders Morris Harris's Elevance Health position peaked at $1.03M in Q2 2024.
- 1,600 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on Sanders Morris Harris's 13F filing for Q2 2026, filed 7 Jul 2026.